Exodus Point Capital Management, LP Celularity Inc Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$0.43 - $4.31 $7,195 - $72,119
-16,733 Closed
0 $0
Q2 2022

Aug 19, 2022
SELL
$2.81 - $12.91 $111,500 - $512,268
-39,680 Reduced 70.34%
16,733 $57,000
Q1 2022

May 13, 2022
BUY
$3.81 - $9.79 $128,202 - $329,423
33,649 Added 147.82%
56,413 $491,000
Q4 2021

Feb 11, 2022
BUY
$4.64 - $7.46 $105,624 - $169,819
22,764 New
22,764 $117,000

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $419M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email